PlainRecalls

Marksans Pharma Limited

Compiled from official public sources by the publisher.

3 recalls on record · Latest: Nov 11, 2020

Subscribe to new Marksans Pharma Limited recalls (RSS)

Agency notice ledger

Federal filing book Marksans Pharma Limited LIGHT-BOOK · SINGLE-AGENCY

#3,814 of 14,151 · 3 notices · 0.003% archive

  • BOOK 3 notices
  • RANK #3,814 of 14,151
  • SHARE 0.003% archive
  • AGENCY FDA Drug (3)
  • CAT drugs
  • CATS 1 category
  • LATEST Nov 11, 2020
  • PHOTO 3B Medical, Inc.

Nearest notice-volume peer: 3B Medical, Inc. (0 notice gap)

Marksans Pharma Limited accounts for about 0.003% of the 104,423-notice archive on 3 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Where Marksans Pharma Limited sits among 14,151 recalling firms

Marksans Pharma Limited ranks 3,814th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Marksans Pharma Limited vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

3 3814th of 14151 higher than 9,908 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Marksans Pharma Limited in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Marksans Pharma Limited holds about 0.003% of archive notices alongside 3 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Nov 11, 2020

Time-Cap Labs, Inc. Metformin Hydrochloride Extended-Release Tablets USP 500 mg, a) 90 count (NDC 49483-623-09) b) 100 count (49483-623-01) c) 500 count (NDC 49483-623-50) and d) 1000 count (NDC 49483-623-10) bottles, Rx Only Manufactured for: Time-Cap Labs, Inc. 7 Michael Avenue Farmingdale, NY 11735, USA, Manufactured by: Marksans Pharma Ltd. Plot No. L-82, L-83, Verna Indl. Estate. Verna Goa-403 722 India NDC 49483-623-50
FDA Drug Moderate Nov 11, 2020

Time-Cap Labs, Inc. Metformin Hydrochloride Extended Release Tablets USP 750 mg, 100 count bottles, Rx Only Manufactured for: Time-Cap Labs, Inc. 7 Michael Avenue Farmingdale, NY 11735, USA Manufactured by: Marksans Pharma Ltd. Plot No. L-82, L-83, Verna Indl. Estate. Verna Goa-403 722 India NDC 49483-624-01
FDA Drug Moderate Jul 1, 2020

Time-Cap Labs, Inc. Metformin Hydrochloride Extended-Release Tablets, USP 500 mg Rx Only 100 Tablets bottles, Manufactured for: Time-Cap Labs, Inc. 7 Michael Avenue Farmingdale, NY 11735, USA Manufactured by: Marksans Pharma Ltd. Plot No, L-82, L-83, Verna Intl. Estate, Verna, Goa-403 722, India NDC 49483-623-01

Marksans Pharma Limited is a small archive contributor

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (3 here).

3B Medical, Inc. 3 7-Eleven, Inc. 3 A & C Best Food Trading 3 A B Nutrition, Inc. 3 A L I Technologies Ltd 3

Similar drugs volume

Nearest multi-notice firms in the same narrow category lane.

A B Nutrition, Inc. 3 Abrams Royal Pharmacy 3 Actavis 3 Ajanta Pharma Ltd. 3

Frequently Asked Questions

How many federal recall notices name Marksans Pharma Limited? ▼
PlainRecalls indexes 3 distinct federal recall events naming Marksans Pharma Limited, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Marksans Pharma Limited sit among other recalling firms? ▼
Marksans Pharma Limited ranks #3,814 of 14,151 by distinct recall-event count among 14,151 firms in this archive (70th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Marksans Pharma Limited's notices? ▼
FDA Drug accounts for 3 of this firm's 3 indexed notices.
What product category dominates Marksans Pharma Limited's filing book? ▼
Filings for Marksans Pharma Limited span 1 product category, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Marksans Pharma Limited: 3 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Marksans Pharma Limited; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026